Semi-Annual Statement Of Income And Retained Earnings

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7724353

Concept 2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
27,496,000,000 JPY
JPY
1,655,000,000 JPY
25,840,000,000 JPY
27,496,000,000 JPY
27,388,000,000 JPY
1,629,000,000 JPY
30,588,000,000 JPY
29,078,000,000 JPY
30,707,000,000 JPY
30,707,000,000 JPY
JPY
Non-operating income
Non-operating income
412,000,000 JPY
412,000,000 JPY
343,000,000 JPY
343,000,000 JPY
Non-operating expenses
Non-operating expenses
53,000,000 JPY
53,000,000 JPY
69,000,000 JPY
69,000,000 JPY
Ordinary profit (loss)
27,854,000,000 JPY
27,747,000,000 JPY
30,863,000,000 JPY
30,981,000,000 JPY
Extraordinary income
Extraordinary income
JPY
JPY
253,000,000 JPY
252,000,000 JPY
Extraordinary losses
Extraordinary losses
168,000,000 JPY
165,000,000 JPY
142,000,000 JPY
142,000,000 JPY
Profit (loss) before income taxes
27,686,000,000 JPY
27,581,000,000 JPY
30,973,000,000 JPY
31,092,000,000 JPY
Income taxes - current
9,206,000,000 JPY
9,170,000,000 JPY
8,108,000,000 JPY
8,147,000,000 JPY
Income taxes - deferred
-563,000,000 JPY
-563,000,000 JPY
924,000,000 JPY
928,000,000 JPY
Profit (loss)
18,974,000,000 JPY
19,043,000,000 JPY
18,974,000,000 JPY
18,974,000,000 JPY
18,974,000,000 JPY
21,940,000,000 JPY
22,017,000,000 JPY
21,940,000,000 JPY
21,940,000,000 JPY
21,940,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.